TRUTAQNI Trademark

Trademark Overview


On Friday, March 27, 2026, a trademark application was filed for TRUTAQNI with the United States Patent and Trademark Office. The USPTO has given the TRUTAQNI trademark a serial number of 99728387. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, May 19, 2026. This trademark is owned by Vera Therapeutics, Inc.. The TRUTAQNI trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment of autoimmune and inflammation-related diseases; therapeutic preparations for the treatment of autoimmune and inflammation-related diseases

Pharmaceutical research and development; medical and scientific research for development of pharmaceuticals and biologics for the treatment of diseases; provision of medical research and scientific research services and medical research and scientific research information in the field of pharmaceuticals, therapeutic preparations, and clinical trials; medical and scientific research, namely, conducting clinical trials for others
trutaqni

General Information


Serial Number99728387
Word MarkTRUTAQNI
Filing DateFriday, March 27, 2026
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, May 19, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 19, 2026

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of autoimmune and inflammation-related diseases; therapeutic preparations for the treatment of autoimmune and inflammation-related diseases
Goods and ServicesPharmaceutical research and development; medical and scientific research for development of pharmaceuticals and biologics for the treatment of diseases; provision of medical research and scientific research services and medical research and scientific research information in the field of pharmaceuticals, therapeutic preparations, and clinical trials; medical and scientific research, namely, conducting clinical trials for others

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 27, 2026
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, March 27, 2026
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVera Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrisbane, CA 94005
US

Party NameVera Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrisbane, CA 94005
US

Trademark Events


Event DateEvent Description
Friday, March 27, 2026NEW APPLICATION ENTERED
Friday, March 27, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 27, 2026APPLICATION FILING RECEIPT MAILED
Wednesday, April 8, 2026ASSIGNED TO EXAMINER
Friday, April 10, 2026EXAMINERS AMENDMENT -WRITTEN
Friday, April 10, 2026EXAMINERS AMENDMENT E-MAILED
Friday, April 10, 2026NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, April 10, 2026EXAMINER'S AMENDMENT ENTERED
Friday, April 17, 2026APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 13, 2026NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 19, 2026PUBLISHED FOR OPPOSITION
Tuesday, May 19, 2026OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED